Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tafenoquine

😃Good
Catalog No. T13083Cas No. 106635-80-7
Alias WR238605, WR 238605

Tafenoquine (WR 238605) is an antimalarial prophylactic agent with schizonticidal activity, useful in hemolytic anemia research.

Tafenoquine

Tafenoquine

😃Good
Purity: 99.56%
Catalog No. T13083Alias WR238605, WR 238605Cas No. 106635-80-7
Tafenoquine (WR 238605) is an antimalarial prophylactic agent with schizonticidal activity, useful in hemolytic anemia research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$33In StockIn Stock
5 mg$53In StockIn Stock
10 mg$86In StockIn Stock
25 mg$183In StockIn Stock
50 mg$296In StockIn Stock
100 mg$471-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.56%
Appearance:Solid
Color:Gray
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Tafenoquine (WR 238605) is an antimalarial prophylactic agent with schizonticidal activity, useful in hemolytic anemia research.
In vitro
Methods: Tafenoquine (WR 238605) was treated with macrophage cell line RAW 264.7, and the in vitro toxicity was evaluated using the MTT assay after 24 hours.
Results: The IC50 value of Tafenoquine against macrophage cell line RAW 264.7 was 5.9μg/mL.[1]
In vivo
Methods: Tafenoquine (WR 238605) (3/6mg/kg, oral) was administered to normal C57BL/6 mice (WT) and humanized/CYP 2D6 knock-in mice, and the antimalarial activity of TQ against P. berghei expressing enzymes was evaluated by monitoring luminescence using an in vivo imaging system.
Results: Tafenoquine at a dose of 3mg/kg showed no antimalarial activity in CYP 2D knock-out mice; when tested at 6mg/kg, the antimalarial activity of TQ in humanized/CYP 2D6 knock-in mice was partially restored.[1]
SynonymsWR238605, WR 238605
Chemical Properties
Molecular Weight463.49
FormulaC24H28F3N3O3
Cas No.106635-80-7
SmilesFC(F)(F)C=1C=CC=C(OC2=C(OC)C=C(NC(C)CCCN)C3=NC(OC)=CC(=C32)C)C1
Relative Density.1.237 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tafenoquine | purchase Tafenoquine | Tafenoquine cost | order Tafenoquine | Tafenoquine chemical structure | Tafenoquine in vivo | Tafenoquine in vitro | Tafenoquine formula | Tafenoquine molecular weight